Search results for: Oncology
Filter search results
OHE Appoints New Deputy Director: Associate Professor Paula Lorgelly
13 August 2015
…research spans three key areas of health economics: the determinants of health, economic evaluation and outcome measurement. She is currently working in the clinical areas of oncology, including genomic testing;…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
…Oncology Initiative, examined the impact of alternative presentations of hypothetical priority setting scenarios, and the extent to which the study respondents agreed with the policy implications of their responses to…
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
…J.C., Hernandez-Villafuerte, K., Shah, K., Mestre-Ferrandiz, J., Garrison, L. and Towse, A., 2014. The Expanding Value Footprint of Oncology Treatments. Consulting Report. London: Office of Health Economics. Richards, M., 2011. Achieving…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…sharing” approach of the CDF to selected non-oncology drugs. The UK CDF remains the “poster child” for jurisdictions seeking to implement conditional coverage / reimbursement schemes. Risk sharing is the…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…decision making. For OHE’s primer on MCDA, click here. 3. The Expanding Value Footprint of Oncology Treatments. Juan Carlos Rejon-Parrilla (OHE), Karla Herandez-Villafuerte (OHE), Koonal K Shah (OHE), Jorge Mestre-Ferrandiz…
Aisha Aidarous
17 December 2025
…technology assessment. Her current research interests include economic evaluation of oncology interventions and exploring inequalities in healthcare decision-making and looks forward to expanding her expertise into additional areas of interest….
Defining Innovation in Medicines and Transforming it into Value
3 July 2013
…here, and on Shah, K.K., Mestre-Ferrandiz, J., Towse, A. and Smythe, E.N. (2013) A review of health technology appraisals: case studies in oncology. International Journal of Technology Assessment in Health Care. 29(1),…
Seven reflections on the UK EQ-5D-5L value set – and what comes next
30 March 2026
…set from the 3L value set could result in a favourable change in the incremental cost-effectiveness ratio (ICER) for a primarily life-extending end-of-life (EOL) oncology treatment. However, from a priority…
Grainne Cremin
1 May 2026
…young people’s mental health programme. Prior to her MSc, Grainne worked for several years in both academic and clinical trial oncology research settings. Her current research interests include the economic…